Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2026-01-03 @ 12:41 AM
Study NCT ID:
NCT05833893
Status:
RECRUITING
Last Update Posted:
2023-04-27
First Post:
2023-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XCOPL - NK/T -P01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None